Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomy.
暂无分享,去创建一个
Alan W Partin | Elizabeth Humphreys | Michael Müntener | A. Partin | P. Walsh | J. Epstein | E. Humphreys | M. Gonzalgo | M. Nielsen | M. Müntener | L. Mangold | Patrick C Walsh | Jonathan I Epstein | Matthew E Nielsen | Mark L Gonzalgo | David J Hernandez | Leslie Mangold | D. Hernandez
[1] M. Terris,et al. Prostate Biopsy Volume Indices do not Predict for Significant Gleason Upgrading , 2005, American journal of clinical oncology.
[2] M. Rubin,et al. Should a Gleason Score Be Assigned to a Minute Focus of Carcinoma on Prostate Biopsy? , 2000, The American journal of surgical pathology.
[3] J. Epstein,et al. Accuracy of biopsy Gleason scores from a large uropathology laboratory: use of a diagnostic protocol to minimize observer variability. , 1998, Urology.
[4] D. Chan,et al. Natural History of Progression After PSA Elevation Following Radical Prostatectomy , 1999 .
[5] S. Piantadosi,et al. Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. , 1997, The American journal of surgical pathology.
[6] Galina Pizov,et al. Correlation of pathologic findings with progression after radical retropubic prostatectomy , 1993, Cancer.
[7] M. Terris,et al. Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen. , 2004, The Journal of urology.
[8] Christopher J Kane,et al. Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score? , 2006, The Journal of urology.
[9] Michael McCormack,et al. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. , 2006 .
[10] B. Trock,et al. Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostate. , 2006, Urology.
[11] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[12] F. Harrell,et al. Evaluating the yield of medical tests. , 1982, JAMA.
[13] A. Haese*,et al. Differences in biopsy features between prostate cancers located in the transition and peripheral zone , 2003, BJU international.
[14] A. D'Amico,et al. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. , 1995, The Journal of urology.
[15] D. Wood,et al. Gleason histologic grading in prostatic carcinoma. Correlation of 18-gauge core biopsy with prostatectomy. , 1994, Archives of pathology & laboratory medicine.
[16] D. Thickman,et al. Effect of the number of core biopsies of the prostate on predicting Gleason score of prostate cancer. , 1996, The Journal of urology.
[17] W. Fair,et al. Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. , 1997, The Journal of urology.
[18] R. Oyasu,et al. The accuracy of diagnostic biopsy specimens in predicting tumor grades by Gleason's classification of radical prostatectomy specimens. , 1984, The Journal of urology.
[19] B. Mian,et al. Role of prostate biopsy schemes in accurate prediction of Gleason scores. , 2006, Urology.
[20] A. Renshaw,et al. Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy. , 1999, International journal of radiation oncology, biology, physics.
[21] Alan W Partin,et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. , 2005, JAMA.
[22] Christopher R King,et al. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. , 2004, International journal of radiation oncology, biology, physics.
[23] D. Theodorescu,et al. The effect of sampling more cores on the predictive accuracy of pathological grade and tumour distribution in the prostate biopsy , 2004, BJU international.
[24] L. Egevad,et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2005, The American journal of surgical pathology.
[25] F. Algaba,et al. Prostate carcinoma II: prognostic factors in prostate needle biopsies , 2006, BJU international.
[26] S. Mills,et al. Gleason histologic grading of prostatic carcinoma. Correlations between biopsy and prostatectomy specimens , 1986, Cancer.
[27] C. King,et al. Patterns of prostate cancer biopsy grading: Trends and clinical implications , 2000, International journal of cancer.
[28] G. Miller,et al. Errors in histological grading by prostatic needle biopsy specimens: frequency and predisposing factors , 2000, The Journal of pathology.
[29] Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. , 2005 .
[30] D. Gleason,et al. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. , 1974, The Journal of urology.
[31] R. Montironi,et al. Prostate carcinoma I: prognostic factors in radical prostatectomy specimens and pelvic lymph nodes , 2006, BJU international.